A Reader Responds: A Common Parasite With An Uncommon Name: Toxoplasma Gondii is Associated with Brain Cancer
source: pixabay.com

A Reader Responds: A Common Parasite With An Uncommon Name: Toxoplasma Gondii is Associated with Brain Cancer

A reader named Fiorella, recently reached out in response to an article we wrote entitled: A Common Parasite With An Uncommon Name: Toxoplasma Gondii is Associated with Brain Cancer. This…

Continue Reading A Reader Responds: A Common Parasite With An Uncommon Name: Toxoplasma Gondii is Associated with Brain Cancer
A Common Parasite With An Uncommon Name: Toxoplasma gondii is Associated with Brain Cancer
source: pixabay.com

A Common Parasite With An Uncommon Name: Toxoplasma gondii is Associated with Brain Cancer

  Toxoplasmosis is transmitted by Toxoplasma gondii, the protozoan parasite which is known to be among the most common parasites worldwide. The infection occurs from contaminated meat, cat feces that…

Continue Reading A Common Parasite With An Uncommon Name: Toxoplasma gondii is Associated with Brain Cancer

New Finding: Overactive Mitochondria Are Responsible for Twenty Percent of Glioblastoma Brain Cancers

Neuroscience News recently carried an article heralding reports of researchers' finding that upwards of twenty percent of lethal glioblastoma brain cancers may be treatable by newly developed drugs. Currently, the…

Continue Reading New Finding: Overactive Mitochondria Are Responsible for Twenty Percent of Glioblastoma Brain Cancers
Tel Aviv University Team Uses CRISPR Technique to Destroy Metastatic Cancer Cells in Mice
source: pixabay.com

Tel Aviv University Team Uses CRISPR Technique to Destroy Metastatic Cancer Cells in Mice

     The latest news from Israeli scientists, published in the Times of Israel, is that researchers at Tel Aviv University have accurately targeted cancerous cells in mice using CRISPR.…

Continue Reading Tel Aviv University Team Uses CRISPR Technique to Destroy Metastatic Cancer Cells in Mice
Trodelvy Gets Orphan Drug Designation as a Glioblastoma Treatment
source: pixabay.com

Trodelvy Gets Orphan Drug Designation as a Glioblastoma Treatment

According to a story from GlobeNewswire, the biopharmaceutical company Immunomedics, Inc., has recently announced that its medication sacituzumab govitecan-hziy (marketed as Trodelvy) has recently earned Orphan Drug designation from the…

Continue Reading Trodelvy Gets Orphan Drug Designation as a Glioblastoma Treatment
Even in Death, This Glioblastoma Patient’s Selfless Lego Donation Drive Touches Thousands of Lives
source: pixabay.com

Even in Death, This Glioblastoma Patient’s Selfless Lego Donation Drive Touches Thousands of Lives

According to a story from 10tv.com, Kellan Shatto is an eight year old boy who really likes to play with Legos. He also has a rare disease: neurofibromatosis. The disease…

Continue Reading Even in Death, This Glioblastoma Patient’s Selfless Lego Donation Drive Touches Thousands of Lives
Zotiraciclib, a New Treatment for Glioma, is Granted Orphan Drug Designation
Source: Pixabay.com

Zotiraciclib, a New Treatment for Glioma, is Granted Orphan Drug Designation

  The European Organization for Research and Treatment of Cancer (EORTC) has been evaluating zotiraciclib, which is a new treatment for glioma. This drug has recently been granted the Orphan…

Continue Reading Zotiraciclib, a New Treatment for Glioma, is Granted Orphan Drug Designation
Recent Study Confirms Validity of the Therapeutic Target of an Experimental Brain Cancer Drug
sbtlneet / Pixabay

Recent Study Confirms Validity of the Therapeutic Target of an Experimental Brain Cancer Drug

According to a story from BioSpace, Oncotelic, Inc., recently announced the publication of a study in the Journal of Clinical Research in Pediatrics. This study appears to back up the therapeutic…

Continue Reading Recent Study Confirms Validity of the Therapeutic Target of an Experimental Brain Cancer Drug

Glioblastoma Clinical Trial: The Henry Ford Cancer Institute Enrolls the World’s First Glioblastoma Patient

  According to a recent article in CheckOrphan, glioblastoma (GBM) is considered to be among the deadliest cancers in the world. Currently, treatment options are surgery, chemotherapy, and radiation. In most cases,…

Continue Reading Glioblastoma Clinical Trial: The Henry Ford Cancer Institute Enrolls the World’s First Glioblastoma Patient